Is pleased to announce that the Company’s wholly owned subsidiary, Egret Bioscience Ltd. has developed and validated a targeted genetic barcode consisting of eight Single Nucleotide Polymorphism for psychedelic mushroom genetic identification. Egret has previously developed and published similar genetic identification tests for the Cannabis Industry and have been offering this service to licensed producers through its affiliated licensed lab, Zenalytic Laboratories Ltd. Lexston Life Sciences shares C.LEXT are trading unchanged at $0.10.
Stocks in play: Lexston Life Sciences
Baystreet.ca - Baystreet - Contributor Content
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here
/AI%20(artificial%20intelligence)/Artificial%20intelligence%20and%20machine%20learning%20concept%20-%20by%20amgun%20via%20iStock.jpg)
/Broadcom%20Inc%20logo%20on%20building-by%20Poetra_%20RH%20via%20Shutterstock.jpg)
/Oracle%20Corp_%20logo%20on%20phone-by%20WonderPix%20via%20Shutterstock.jpg)
